CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 132 enrolled
Drug / intervention
Metamizol +4 moredrug
Likely dose
Tramadol 2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02971540
NCT02971540N/ACompleted

Comparative, Randomized Trial of SPI-directed Intravenous Analgesia Using Metamizole With Tramadol Versus Preemptive Wound Infiltration Using 0,2 % Ropivacaine With Fentanyl or 0,2 % Bupivacaine With Fentanyl for Lumbar Discectomy

Medical University of Silesia·interventional·Posted Nov 23, 2016·Updated Apr 16, 2019

In Brief

A clinical study evaluating Metamizol, Tramadol, and 3 other interventions for Lumbar Disc Disease. Completed, enrolled 132 participants across 1 site.

Detailed Summary

The aim of this randomized trial is to assess the efficacy of analgesia for lumbar discectomy and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received either preemptive local tissue infiltration at surgical site using either 0,2% ropivacaine with fentanyl or 0,2% bupivacaine with fenthanyl or preemptive intravenous infusion using metamizole and tramadol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPoland

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 23, 2016
Enrollment StartFeb 1, 2016
Primary CompletionJul 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.6 years ago

Interventions

Metamizoldrug

in group A patients will receive pre-emptive analgesia using intravenous infusion of metamizol in a single dose of 1-1,25 gram with following intravenous infusion of 5 grams per day.

Tramadoldrug

in group A patients will receive pre-emptive analgesia using intravenous infusion of tramadol in a single dose of 2 mg per hg of body weight with following intravenous infusion of 400 mg per day.

Bupivacainedrug

patients in group BF will receive local wound infiltration with a solution of 0,2% bupivacaine in a volume of 10 ml per segment of vertrebral columne.

Ropivacainedrug

patients in group RF will receive local wound infiltration with a solution of 0,2% ropivacaine in a volume of 10 ml per segment of vertrebral columne.

control groupother

patients will receive no pre-emptive analgesia. intraoperatively standard dose of fentanyl will be used.